Insurance Licensing · Property & Casualty, Life & Health · July 2026
45
comments in July
▲ 80%  vs its own June Its deepest  month since launch

Insurance Licensing found its voice in July, its deepest month since launch.

Comments
45
Replies written into Insurance threads in July.
▲ 80%  vs its own June (25)
Members talking
39
Members posted or commented in July.
▲ 63%  vs its own June (24)
Conversation depth
3.5
Replies per post, the average number each new thread draws.
▲ Up from 2.3  in its own June
The shape of it

Insurance Licensing had no comment line at all until May.

The runway

The audience behind the conversation.

Students on the Insurance Licensing roster
2,028 in June. 4,446 in July, though part of that is role provisioning catching up.
Lead attribution
$9,389

attributed to Insurance Licensing in July.

Year to date$46,441

Adoption and re-purchase figures for July are pending the data team and will be added here when they land.

Insurance went from silence to real conversation in three months: 13 threads drew 45 replies. The next move is turning a roster of 4,446 into a habit.

More charts  the full series for this community ▼
Logged in Users
Signed-in members, Vanilla. Not the same as GA site visitors.
Posts and Comments
Monthly volume, both series.
Students
Members on the student roster.
Lead Attribution
Attributed revenue per month. Click a bar to see the three categories behind it.
Behind July 2026
Category 1Net new leadsPeople with no prior Kaplan record before they arrived.
−−
Category 2Existing leads, never convertedPeople already known to Kaplan who had never bought anything.
−−
Category 3Past studentsPeople who had studied with Kaplan before and bought again.
−−

Category detail starts with June 2026, the first month the workbook can be differenced.

Logged in Users is the Vanilla analytics Active Users figure, read from the Vanilla dashboard: 2,490 in July against 1,401 in June. It counts signed-in members and is not the same as GA active users, who are site visitors. This community has no 2025 baseline, so the emphasis chart above runs on a single series. Adoption and re-purchase are pending the data team.